Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaotong Liao

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|August 8, 2024
Targeting the STAT3 pathway with STAT3 degradersZhijie Wang, Xiaotong Liao, Haiqi He, et al.
Journal of Medicinal Chemistry|April 10, 2024
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 PathwayZhijie Wang, Lin Yuan, Xiaotong Liao, et al.
Journal of Medicinal Chemistry|April 15, 2025
Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor ImmunotherapyZhijie Wang, HaiQi He, Xiaotong Liao, et al.
Frontiers in Microbiology|June 1, 2026
Preparation and bioactivity of probiotic-fermented lotus seed and lily bulb beverageXiaoqing Xu, Yifan Wang, Lingshan Liang, et al.
European Journal of Medicinal Chemistry|January 25, 2026
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunityZhijie Wang, HaiQi He, Jianwei Xu, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|August 8, 2024
Targeting the STAT3 pathway with STAT3 degradersZhijie Wang, Xiaotong Liao, Haiqi He, et al.
Journal of Medicinal Chemistry|April 10, 2024
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 PathwayZhijie Wang, Lin Yuan, Xiaotong Liao, et al.
Journal of Medicinal Chemistry|April 15, 2025
Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor ImmunotherapyZhijie Wang, HaiQi He, Xiaotong Liao, et al.
Frontiers in Microbiology|June 1, 2026
Preparation and bioactivity of probiotic-fermented lotus seed and lily bulb beverageXiaoqing Xu, Yifan Wang, Lingshan Liang, et al.
European Journal of Medicinal Chemistry|January 25, 2026
Discovery of the first dual PD-L1/JAK inhibitor with enhanced in vivo antitumor immunityZhijie Wang, HaiQi He, Jianwei Xu, et al.
Pageof 1